miR-3113-5p, miR-223-3p, miR-133a-3p, and miR-499a-5p are sensitive biomarkers to diagnose sudden cardiac death
Open Access
- 31 July 2021
- journal article
- research article
- Published by Springer Nature in Diagnostic Pathology
- Vol. 16 (1) , 1-13
Abstract
Background: Sudden cardiac death (SCD) remains a great health threat and diagnostic challenge, especially those cases without positive autopsy findings. Molecular biomarkers have been urgently needed for the diagnosis of SCD displaying negative autopsy results. Due to their nature of stability, microRNAs (miRNAs) have emerged as promising diagnostic biomarkers for cardiovascular diseases. Methods: This study investigated whether specific cardio-miRNAs (miR-3113-5p, miR-223-3p, miR-499a-5p, and miR-133a-3p) could serve as potential biomarkers for the diagnosis of SCD. Thirty-four SCD cases were selected, 18 categorized as SCD with negative autopsy (SCD-negative autopsy) findings and 16 as SCD with positive autopsy (SCD-positive autopsy) findings such as coronary atherosclerosis and gross myocardial scar. Carbon monoxide (CO) intoxication (n = 14) and fatal injury death (n = 14) that displayed no pathological changes of myocardium were selected as control group, respectively. Histological analyses were performed to reveal the pathological changes and real-time quantitative polymerase chain reaction (RT-qPCR) was used to determine the expression of those miRNAs. Results: It showed that heart samples from the SCD-negative autopsy group displayed no remarkable difference with regard to the expression of cleaved-caspase3, CD31, and CD68 and the extent of fibrotic tissue accumulation when compared with control samples. The four cardio-miRNAs were significantly up-regulated in the SCD samples as compared with control. When discriminating SCD from controls, receiver operating characteristic (ROC) curve analysis revealed that the areas under the curve (AUC) of these 4 miRNAs were from 0.7839 to 0.9043 with sensitivity of 64.71–97.06% and specificity of 70–100%. Moreover, when discriminating the specific causes of SCD, the four miRNA expressions increased in the heart from the SCD-negative autopsy group as relative to that from the SCD-positive autopsy group, and a combination of two miRNAs presented higher diagnostic value (AUC = 0.7407–0.8667). Conclusion: miR-3113-5p, miR-223-3p, miR-499a-5p, and miR-133a-3p may serve as independent diagnostic biomarkers for SCD, and a combination of two of these miRNAs could further discriminate detailed causes of SCD.Keywords
All Related Versions
Funding Information
- open project of Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases of Ministry of Education (XN201810)
- Research Project of Gannan Medical University (XN201924 and YB201811)
- Science and technology project of Jiangxi Provincial Department of Education (GJJ160979 and GJJ180794)
- open project of Key Laboratory of Forensic Pathology, Ministry of Public Security (GAFYBL201903)
This publication has 54 references indexed in Scilit:
- Prevalence of arrhythmia-associated gene mutations and risk of sudden cardiac death in the Finnish populationAnnals of Medicine, 2013
- Angiotensin converting enzyme DD genotype is associated with acute coronary syndrome severity and sudden cardiac death in Taiwan: a case-control emergency room studyBMC Cardiovascular Disorders, 2012
- Role of miR-1 and miR-133a in myocardial ischemic postconditioningJournal of Biomedical Science, 2011
- The peripheral blood mononuclear cell microRNA signature of coronary artery diseaseBiochemical and Biophysical Research Communications, 2010
- Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humansEuropean Heart Journal, 2010
- Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA‐1British Journal of Pharmacology, 2009
- MicroRNA Classifiers for Predicting Prognosis of Squamous Cell Lung CancerCancer Research, 2009
- Circulating microRNAs as stable blood-based markers for cancer detectionProceedings of the National Academy of Sciences, 2008
- The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2Nature Medicine, 2007
- The application of selected histochemical and immunohistochemical markers and procedures to the diagnosis of early myocardial damageInternational journal of legal medicine, 1993